Related Experiment Video
Updated: Aug 14, 2026
09:25
The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
[Exhaustion and fatigue--a neglected problem in hematologic oncology]
J Zahner1, J Meran, M Karthaus
1Abteilung Medizin und Forschung, Janssen-Cilag GmbH, D-41470 Neuss, Deutschland. jzahner@jacde.jhj.com
Wiener Medizinische Wochenschrift (1946)
|January 16, 2002
Summary
Cancer patients frequently experience exhaustion and tiredness due to cancer and its treatments. While previously overlooked, new research explores causes and innovative treatments like Erythropoietin for cancer-related fatigue.
Area of Science:
- Oncology
- Palliative Care
- Symptom Management
Context:
- Exhaustion and tiredness are prevalent symptoms in cancer patients.
- These symptoms stem from the tumor and cancer treatments like chemotherapy, radiation, and cytokine therapy.
- Historically, these symptoms were considered inevitable side effects, leading to limited research and attention.
Purpose:
- To summarize the causes and characteristics of exhaustion and tiredness in cancer patients.
- To highlight the distinction between general tumor fatigue and specific physical exhaustion/tiredness.
- To introduce current and innovative therapeutic approaches for managing these debilitating symptoms.
Summary:
- Cancer-induced exhaustion and tiredness are multifactorial, driven by anemia, cachexia, and treatment toxicities, not just lack of sleep.
- Validated tools like FACT-An and EORTC QLQ-C30 identify these symptoms, though a dedicated exhaustion scale is lacking.
- Therapeutic strategies include behavioral interventions, psychostimulants, and novel treatments such as Erythropoietin.
Impact:
- Improved understanding of cancer-related exhaustion and tiredness.
- Recognition of the need for dedicated symptom assessment tools.
- Potential for enhanced patient quality of life through targeted interventions like Erythropoietin.
Related Concept Videos
01:24Muscle Recovery and Fatigue
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:21Fatigue
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.